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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S259activities as putting on their clothes. In addition, individuals with
multiple co-morbidities had even more complex and challenging self-
management experiences, which resulted in family and friends taking
on additional “work” to compensate. The multi-joint nature of OA and
other co-morbidities further complicated self-management. Many
participants described experiencing pain or stiffness in multiple joints
at the same time as a result of OA. Additionally, several participants had
other health conditions that affected their ability to participate in self-
management activities.
Conclusions: These ﬁndings suggest that previous research on OA self-
management overlooks the everyday modiﬁcations patients already
make to manage their disease prior to surgery, and additionally focuses
solely on the individual patient, ignoring the social context of their lives.
We found that self-management is not an individual activity but rather
can involve the individual's spouse, children, friends and/or co-workers.
Further, self-management is complicated by the multi-joint nature of
OA and by comorbidities. Future approaches to self-management in OA
need to consider these additional issues/aspects as well as the various
psychosocial factors that may inﬂuence patients’ experiences.
498
THE OA TRIAL BANK: INDIVIDUAL PATIENT DATA META-ANALYSIS OF
TRIALS INVESTIGATING THE EFFECTIVENESS OF INTRA-ARTICULAR
CORTICOSTEROID INJECTIONS IN PATIENTS WITH KNEE OR HIP OA
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Purpose: Based on small to moderate effectiveness of the wide range of
symptomatic treatments in osteoarthritis (OA), and the heterogeneity of
OA patients, treatment guidelines for OA have stressed the need for
research on clinical predictors of response to different treatments. A
meta-analysis for quantifying interaction effects using Individual
Patient Data (IPD) is considered to be the gold standard for subgroup
analysis. An initiative to collect and analyse IPD in OA research is
commenced by the ‘OATrial Bank’. The general purpose of this initiative
is to reach consensus on the rules for cooperation in a consortium and
to develop and explore the methodological issues of meta-analysis with
individual OA patient data. The ﬁrst meta-analysis will evaluate the
efﬁcacy of intra-articular (IA) corticosteroids for knee or hip OA in
speciﬁc subgroups of patients with severe pain and (mild) inﬂamma-
tory signs, over both short and long term follow-up, using IPD from
existing trials.
Methods: The OA Trial Bank is set-up as a worldwide collaboration
that initiates meta-analyses on predeﬁned subgroups of OA patients
using data from existing studies. An executive coordinator will
approach internationally acknowledged clinical and epidemiological
researchers in the OA ﬁeld to formalize the steering committee. The
committee will agree on the organisational structure and tasks of all
parties involved, agree on the design and methods of meta-analyses,
the deﬁnition of subgroups and statistical analyses. A licence agree-
ment will be developed to guarantee legal issues between the OA Trial
Bank and data-deliverers. For the ﬁrst IPD analysis, randomised
controlled trials (RCTs) evaluating one or more IA corticosteroid
preparations in patients with OA of the knee or hip, published from
1995 up to June 2012, will be selected from the existing literature.
Corresponding authors of eligible trials will be approached and asked
to cooperate in this project. All data-deliverers will be asked to sign
the licence agreement before the data is transferred to the OA Trial
Bank. Data obtained from the original databases include patient-,
disease- and study characteristics and outcome measures. To assess
potential subgroup effects, a ﬁxed-effects linear regression model will
be used to calculate interaction effects.
Results: A chairman, steering committee and an executive coordinator
formalize the OA Trial Bank (Figure 1). The steering committee guar-
antees continuity of the OA Trial Bank and supervises the executive
coordinator. The committee has approved and agreed the organisa-
tional structure and the tasks of the parties involved (Figure 1). The
content of the licence agreement was provided by the committee,
including data access, transfer and storage, predeﬁned analyses, conﬁ-
dentiality and reliability statement, authorship. A total of 44publications were selected as ‘potentially eligible’. Authors have been
contacted with a data-delivery request.
Conclusions: The international character of the steering committee, the
multidisciplinary structure, the patient involvement and the endorse-
ment of the OARSI and EULAR will all strengthen this initiative and
inspire trialists, i.e. data-deliverers, to join this initiative.
Figure 1. ﬂow chart of organization OA Trial Bank.Ă
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A META-ETHNOGRAPHY OF PATIENTS' EXPERIENCE OF CHRONIC
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Purpose: Many people suffer from musculoskeletal (MSK) pain. This
pain often has no medical explanation and does not go away. Some
people ﬁnd it so devastating that at times they would rather die than go
on in pain. A greater understanding of patients’ experiences of pain
could have an impact on healthcare in this group. Qualitative research
aims to understand experience, but the increasing number of qualita-
tive studies can make it difﬁcult to use this knowledge to inform clinical
practice. A synthesis of qualitative research would help us to under-
stand what it is like to have chronic MSK pain. Speciﬁcally, it would help
us understand peoples’ experience of healthcare with the aim of
improving it. The aim of this study is to: increase our understanding of
patients’ experiences of chronic MSK pain; utilise existing research
knowledge to improve understanding; and contribute to the develop-
ment of methods for qualitative research synthesis.
Methods: We used the methods of meta-ethnography developed by
Noblit and Hare, which aim to develop concepts that help us to
understand a particular experience, by synthesising research ﬁndings.
We searched six electronic bibliographic databases, and included
studies up until the ﬁnal search in February 2012. We also hand
searched particular journals known to report qualitative studies, and
looked through reference lists. We appraised each study to decide
whether or not to include it. We included 77 qualitative studies that
explored adults’ experience of chronic non-malignant musculoskeletal
(MSK) pain. Twenty eight of these studies explored the experience of
Fibromyalgia.
Results: Our model reveals the concept of an adversarial struggle to
explain the experience of chronic MSK pain. We describe a struggle to
afﬁrm self and explain suffering. Although alienated from the
biomedical model, the person feels compelled to re-enter the health-
care system in order to establish legitimacy. Despite a fundamental
need to feel that the health professional is alongside them, people with
chronic pain do not feel believed or valued. Chronic pain is experienced
as non-legitimate, and the person uses strategies to gain legitimacy; for
